Older teens are more likely to be affected by anemia caused by the Oxford-AstraZeneca vaccine, say UK medical authorities.
The Medicines and Healthcare product Regulatory Agency (MHRA) said in the UK there are 209 cases of mixed platelet aggregation after receiving the Oxford-AstraZeneca jab vaccine, which died at 41, as of April 21.
That comes from 168 cases and 32 deaths last week.
The information, published by the MHRA for the first time on Thursday, also provides damage to the jab-affected part.
It shows 23 cases of people between the ages of 18 to 29, 27 of them in their 30s, 30 in their 40s, 59 of people in their 50s and 57 years of age 60 or older, and unknown age in cases of attraction.
About a quarter of the blood loss was in people under the age of 40, and two-thirds of them were under the age of 60, reported.
Is that about you? Tell us at email@example.com
This is in stark contrast to the number of people who received the vaccine, with recent NHS England reports showing that 5.5 million people under the age of 45 received the first dose by April 25 compared to 22.6 million of those 45 and beyond.
The MHRA said the findings indicate that there are significant cases reported in the younger age group and recommend that this evidence should be considered when considering vaccination.
Chief executive Dr June Raine said there was no risk-free drug or vaccine, but said blood clots were “extremely rare.”
He added: “The benefits of the vaccine far outweigh any suffering that many people experience.
“It is very important that people come to get vaccinated when they are invited to do so.
“We urge anyone who suspects that they have experienced a problem associated with their COVID-19 vaccine to report any. Corona infection Yellow Card Page. ”
The total number of Covid-19 Vaccine AstraZeneca drugs released in the UK by April 21 was 22 million giving a total of 9.3 million, says MHRA.
The data also showed that 120 cases were recorded among 89 women and men between the ages of 18 to 93, and the overall death toll was 19%.